Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2007-10-09
2007-10-09
Le, Long V. (Department: 1641)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S007900, C435S007910, C435S962000, C435S973000
Reexamination Certificate
active
11213557
ABSTRACT:
The instant invention describes an analytical assay to accurately measure an analyte in the presence of an interfering substance.
REFERENCES:
patent: 4968603 (1990-11-01), Slamon et al.
patent: 5480792 (1996-01-01), Buechler et al.
patent: 5501983 (1996-03-01), Lilja et al.
patent: 5518887 (1996-05-01), Parsons et al.
patent: 5821337 (1998-10-01), Carter et al.
patent: 6235535 (2001-05-01), Keinanen et al.
patent: 2002/0051985 (2002-05-01), Whitten et al.
Aasland et al., “Expression of oncogenes in thyroid tumours: Coexpression of c-erb B2
eu and c-erbB”Br. J. Cancer57:358-363 (1988).
Baselga et al., “Phase II Study of Weekly Intravenous Recombinant Humanized Anti-p185HER2Monoclonal Antibody in Patients with HER2
eu-Overexpressiing Metastatic Breast Cancer”J. Clin. Oncol. 14:737-744 (1996).
Bastiaens and Squire, “Fluorescence lifetime imaging microscopy: spatial resolution of biochemical processes in the cell”Trends Cells Biol. 9:48-52 (1999).
Borst et al., “Oncogene Alterations in Endometrial Carcinoma”Gynecol. Oncol., 38:364 (1990).
Carter et al., “Humanization of an anti-p185 HER2 antibody for human cancer therapy”Proc. Natl. Acad. Sci. USA89: 4285 (1992).
Cohen et al., “Expression pattern of the neu (NGL) gene-encoded growth factor receptor protein (p185neu) in normal and transformed tissues of the disgestive tract”Oncogene, 4:81-88 (1989).
Fehm et al., “The Prognostic Significance of c-erbB-2 Serum Protein in Metastatic Breast Cancer”Oncology55:33-38 (1998).
Fukushigi et al., “Localization of a Novel v-erbB-Related Gene, c-erbB-2, on Human Chromosome 17 and Its Amplification in a Gastric Cancer Cell Line”Mol Cell Biol., 6:955-958 (1986).
Geurin et al., “Overexpression of Either c-myc or c-erbB-2
eu Proto-Oncogenes in Human Breast Carcinomas: Correlation with Poor Prognosis”Oncogene Res., 3:21-31 (1988).
Gu et al., “Overexpression of her-2
eu in human prostate cancer and benign hyoerplasia”Cancer Lett. 99:185-9 (1996).
Hudziak et al., “p185HER2Monoclonal Antibody Has Antiproliferative Effects In Vitro and Sensitizes Human Breast Tumor Cells to Tumor Necrosis Factor”Mol. Cell. Biol. 9(3):1165-1172 (1989).
Kern et al., “p185neuExpression in Human Lung Adenocarcinomas Predicts Shortened Survival”Cancer Res., 50:5184 (1990).
King et al., “Amplification of a Novel v-erbB-Related Gene in a Human Mammary Carcinome”Science, 229:974 (1985).
Kobayashi et al. “Detectuib of Microfilarial Antigen in Circulating Immune Complex from Sera of Wuchereria Bancrofti-infected individuals”Am. J. Trop. Med. Hyg. 57:200-204 (1997).
Park et al., “Amplification, Overexpression, and Rearrangement of the erbB-2 Protooncogene in Primary Human Stomach Carcinomas”Cancer Res., 49:6605 (1989).
Ross et al. “Prognostic Significance of HER-2
eu Gene”Cancer79:2162-70 (1997).
Ross et al., “HER-2
eu Gene Amplification Status in Prostate Cancer by Fluorescence in Situ Hybridization”Hum. Pathol. 28:827-33 (1997).
Sadasivan et al., “Overexpression of HER-2
eu May be an Indicator of Poor Prognosis in Prostate Cancer”J. Urol, 150:126-31 (1993).
Schmerr et al., “Improvements in a competition assay to detect scrapie prion protein by capillary electrophoresis”J. Chromatogr. B. Biomed. Appl. 681: 29-35 (1996).
Schüpbach et al., “Heat-mediated immune complex dissociation and enzyme-linked immunosorbent assay signal amplifications render p24 antigen detection in plasma as sensitive as HIV-1 RNA detection by polymerase chain reaction”J. Infect. Dis. 170: 318-324 (1994).
Slamon et al., “Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2
eu Oncogene”Science, 235:177-182 (1987).
Slamon et al., “Studies of the HER-2
eu Proto-oncogene in Human Breast and Ovarian Cancer”Science, 244:707-712 (1989).
Steindl et al., “A simple and robust method for the complete dissociation of HIV-1 p24 and other antigens from immune complexes in serum and plasma samples”J. Immunol. Methods217: 143-151 (1998).
Weiner et al., “Expression of the neu Gene-encoded Protein (P185neu) in Human Non-Small Cell Carcinomas of the Lung”Cancer Res., 50:421-425 (1990).
Williams et al., “Expression of c-erbB-2 in Human Pancreatic Adenicarcinomas”Pathobiology59:46-52 (1991).
Yamauchi et al., “Prediction of Response to Antiestrogen Therapy in Advanced Breast Cancer Patients by Pretreatment Circulating Levels of Extracellular Dpomain of the HER-2/c-neu Portein”J. Clin. Oncol. 15: 2518-2525 (1997).
Yokota et al., “Amplication of c-erbB-2 Oncogene in Human Adenocarcinomas in Vivo”Lancet: 1:765-767 (1986).
Yonemura et al., “Evaluation of Immunoreactivity for erbB-2 Portein as a Marker of Poor Short Term Pregnosis in Gastric Cancer”Cancer Res., 51:1034 (1991).
Zhau et al., “Amplification and Expression of the c-erb B-2
eu Proto-Oncogene in Human Bladder Cancer”Mol. Carcinog., 3:354-357 (1990).
Dreger, Esq. Ginger R.
Genentech Inc.
Heller Ehrman LLP
Jacob Cheu
Lee Wendy
LandOfFree
Analytical method does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Analytical method, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Analytical method will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3845322